• A scoping review of the evidence on pharmacological and non-pharmacological interventions for idiopathic hypersomnia
• Absence of multiple sleep-onset rapid eye movement periods (SOREMPs) is not a specific feature of patients with pathological sleep prolongation
• Allowing ad libitum sleep during overnight polysomnography impacts Multiple Sleep Latency Test results in patients being assessed for hypersomnolence
• Altered reinforcement learning in Narcolepsy type I and other central disorders of hypersomnolence
• Applicability of the Sustained Attention to Response Task (SART) in hypersomnolence: Experience and results from a tertiary referral center
• Approach to a sleepy child: Diagnosis and treatment of excessive daytime sleepiness in children and adolescents
• Are unrefreshing naps associated with nocturnal sleep architecture specificities in idiopathic hypersomnia?
• Assessment of the Relationship between Non-motor features and Severity of Parkinson's Disease Patients in Bangladesh
• Association between idiopathic hypersomnia and a genetic variant in the PER3 gene
• Autonomic cardiovascular control is unaffected in children referred for assessment of excessive daytime sleepiness
• Biochemistry, Gamma Aminobutyric Acid
• Biochemistry, Gamma Aminobutyric Acid
• Brain fog in central disorders of hypersomnolence: a review
• Cardiovascular burden of narcolepsy: what have we learned and what do we still need to know?
• Central Disorders of Hypersomnolence
• Cerebrospinal fluid proteomics in recent-onset Narcolepsy type 1 reveals activation of the complement system
• Clinical considerations in the treatment of idiopathic hypersomnia
• Clinical Evaluation and Management of Narcolepsy in Children and Adolescents
• Commonly Used Therapeutics Associated with Changes in Arousal Inhibit GABA_AR Activation
• Correction to: Lipocalin-type prostaglandin D synthase levels increase in patients with narcolepsy and idiopathic hypersomnia
• Differences in psychosocial factors and sleep study findings between delayed sleep-wake phase disorder and hypersomnia in teenagers
• Differentiation of central disorders of hypersomnolence with manual and artificial-intelligence-derived polysomnographic measures
• Disentangling the complex landscape of sleep-wake disorders with data-driven phenotyping: A study of the Bernese center
• Dosing Optimization of Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia in Adults: Consensus Recommendations
• Effectiveness and optimization of low-sodium oxybate in participants with narcolepsy switching from a high-sodium oxybate: data from the SEGUE study
• Evaluation of hypersomnolence: From symptoms to diagnosis, a multidimensional approach
• Eyelid Closure Behavior of Patients with Idiopathic and Nonorganic Hypersomnia, Narcolepsy-Cataplexy, and Healthy Controls in the Maintenance of Wakefulness Test
• Face validation and pharmacologic analysis of Sik3(Sleepy) mutant mouse as a possible model of idiopathic hypersomnia
• Face validation and pharmacologic analysis of Sik3^Sleepy mutant mouse as a possible model of idiopathic hypersomnia
• From physiological awakening to pathological sleep inertia: Neurophysiological and behavioural characteristics of the sleep-to-wake transition
• Functional recovery after ischemic stroke: Impact of different sleep health parameters
• Genetics and epigenetics of rare hypersomnia
• Genome-wide association study of idiopathic hypersomnia in a Japanese population
• Guardians of Rest? Investigating the gut microbiota in central hypersomnolence disorders
• Guidelines for the assessment and management of residual sleepiness in obstructive apnea-hypopnea syndrome: Endorsed by the French Sleep Research and Medicine Society (SFRMS) and the French Speaking Society of Respiratory Diseases (SPLF)
• High-resolution HLA sequencing and hypocretin receptor 2 autoantibodies in narcolepsy type 1 and type 2
• How reliable is a simplified MSLT nap termination protocol?
• Hyperactivity in patients with narcolepsy and idiopathic hypersomnia: an exploratory study
• Identifying time-resolved features of nocturnal sleep characteristics of narcolepsy using machine learning
• Idiopathic Hypersomnia
• Idiopathic Hypersomnia
• Idiopathic hypersomnia and Kleine-Levin syndrome
• Idiopathic Hypersomnia and Kleine-Levin Syndrome: Primary Disorders of Hypersomnolence Beyond Narcolepsy
• Idiopathic hypersomnia with a video recording of a spontaneous sleep attack: A case report
• Idiopathic hypersomnia years after the diagnosis
• Idiopathic hypersomnia: a kind of sleep disorder that cannot be ignored
• Idiopathic Hypersomnia: Neurobiology, Diagnosis, and Management
• Idiopathic hypersomnia: the long journey from classification to an efficacious drug
• Impairment in Functioning and Quality of Life in Patients with Idiopathic Hypersomnia: The Real World Idiopathic Hypersomnia Outcomes Study (ARISE)
• Increase in the Number and Duration of Sleep Episodes During Class After Reopening of Schools Following Closure due to COVID-19
• Insights from a 10-year Australasian idiopathic hypersomnia patient data registry study
• Investigation of anti-neuronal antibodies and disparity in central hypersomnias
• Is there a role for repeating the multiple sleep latency test across childhood when initially non-diagnostic?
• Letter to editor
• Long sleep time and excessive need for sleep: State of the art and perspectives
• Long-term efficacy and safety of low-sodium oxybate in an open-label extension period of a placebo-controlled, double-blind, randomized withdrawal study in adults with idiopathic hypersomnia
• Long-Term Treatment of Narcolepsy and Idiopathic Hypersomnia with Low-Sodium Oxybate
• Microglia Density and Its Association With Disease Duration, Severity, and Orexin Levels in Patients With Narcolepsy Type 1
• Multiple Sleep Latency Test/Maintenance of Wakefulness Test and Central Hypersomnias: Evolving Diagnostic and Therapeutic Approaches
• Narcolepsies, update in 2023
• Narcolepsy and Idiopathic Hypersomnia
• Narcolepsy and rapid eye movement sleep
• Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy
• Narcolepsy Severity Scale-2 and Idiopathic Hypersomnia Severity Scale to better quantify symptoms severity and consequences in Narcolepsy type 2
• New insights and potential clinical implications of the odds ratio product
• Novel Objective Measures of Hypersomnolence
• PET Study of Microglial Activation in Kleine-Levin Syndrome
• Pharmacological management of narcolepsy in children and adolescents
• Post-COVID central hypersomnia, a treatable trait in long COVID: 4 case reports
• Potential immunological triggers for narcolepsy and idiopathic hypersomnia: Real-world insights on infections and influenza vaccinations
• Potential teratogenicity of modafinil - Conflicting evidence, need for research
• Prevalence and Course of Idiopathic Hypersomnia in the Wisconsin Sleep Cohort Study
• Pupillometry to differentiate idiopathic hypersomnia from narcolepsy type 1
• Rethinking the Role of Orexin in the Regulation of REM Sleep and Appetite
• Role of Daytime Continuous Polysomnography in the Diagnosis of Pediatric Narcolepsy Type 1
• Safety and efficacy of pitolisant in children aged 6 years or older with narcolepsy with or without cataplexy: a double-blind, randomised, placebo-controlled trial
• Safety and pharmacodynamics of a single infusion of danavorexton in adults with idiopathic hypersomnia
• Single cell transcriptomics of cerebrospinal fluid cells from patients with recent-onset narcolepsy
• Single sessions of transcranial direct current stimulation and transcranial random noise stimulation exert no effect on sleepiness in patients with narcolepsy and idiopathic hypersomnia
• Skin temperature as a predictor of on-the-road driving performance in people with central disorders of hypersomnolence
• Sleep architecture in idiopathic hypersomnia: the influence of age, sex, and body mass index
• Sleep Disorders in Childhood
• Sleepiness in adults: An umbrella review of a complex construct
• Sleepy Kids: are the current diagnostic criteria for multiple sleep latency tests enough?
• Stimulating hypocretin receptors improves sleepiness and vigilance in idiopathic hypersomnia: lessons from a proof of concept study
• Successful Challenge With Brexpiprazole for Idiopathic Hypersomnia in a Patient With Bipolar Disorder: A Case Report
• Symptom Severity and Treatment Satisfaction in Patients with Idiopathic Hypersomnia: The Real World Idiopathic Hypersomnia Outcomes Study (ARISE)
• Temporal patterns of sleep latency in central hypersomnia and attention deficit hyperactivity disorder: a cluster analysis exploration using Multiple Sleep Latency Test
• The actigraphic evaluation of daytime sleep in central disorders of hypersomnolence: comparison with polysomnography
• The electroretinography to identify biomarkers of idiopathic hypersomnia and narcolepsy type 1
• The immunopathogenesis of narcolepsy type 1
• The patient burden of nocturnal polyuria in the United States: Results from the epidemiology of nocturnal polyuria (EpiNP) study
• The Role of Sodium Oxybate in Idiopathic Hypersomnia: A Case Report Showing Improvement of Excessive Daytime Sleepiness and Reduced Symptoms
• The transcriptomics profiling of blood CD4 and CD8 T-cells in narcolepsy type I
• The value of using ELISA to detect orexin-A in cerebrospinal fluid in the diagnosis of narcolepsy
• Unrefreshing naps and sleep architecture during the multiple sleep latency test in idiopathic hypersomnia
• Update on the treatment of idiopathic hypersomnia: Progress, challenges, and expert opinion
• Validation and performance of the sleep inertia questionnaire in central disorders of hypersomnolence
• Wakefulness-promoting agents for severe fatigue: to use or not to use?
• What respiratory physicians should know about narcolepsy and other hypersomnias